zylacta.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home |
| Description | Developing natural microbial products for medical Home Drug Development Drug Development Clinical Observations Technology Technology Natural Products Synthetic Biology Semisynthetic Chemistry Partners Par |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 206.188.192.143 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
zylacta.com Valuation
|
US$689,188
Last updated: 2023-05-15 02:27:46
zylacta.com has Semrush global rank of 15,357,645. zylacta.com has an estimated worth of US$ 689,188, based on its estimated Ads revenue. zylacta.com receives approximately 79,522 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.143. According to SiteAdvisor, zylacta.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$689,188 |
| Daily Ads Revenue | US$637 |
| Monthly Ads Revenue | US$19,086 |
| Yearly Ads Revenue | US$229,023 |
| Daily Unique Visitors | 5,302 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| zylacta.com. | A | 7199 | IP: 206.188.192.143 |
| zylacta.com. | NS | 7200 | NS Record: ns57.worldnic.com. |
| zylacta.com. | NS | 7200 | NS Record: ns58.worldnic.com. |
| zylacta.com. | MX | 7200 | MX Record: 10 mx1.netsolmail.net. |
HtmlToTextCheckTime:2023-05-15 02:27:46
| Home Drug Development Drug Development Clinical Observations Technology Technology Natural Products Synthetic Biology Semisynthetic Chemistry Partners Parnerss Scaled manufacture News & Media News & Media Publications Investor Info Contact us Developing natural microbial products for medical uses Zylacta Corporation is an early stage biotech company based in Gaithersburg, Maryland, focused on the discovery and development of peptidoglycan-based products for immunotherapy. We offer proven methods to develop these hits into drugs via a gene-based technology that is rooted in our expertice in genomics of bacterial peptidoglycan synthesis, maturation and "shedding". We discovered that certain peptidoglycan fragments represent important new classes of potential drugs, which Zylacta is uniquely positioned to develop. These compounds interact with essential elements of innate immunity and demonstrate high potential in the treatment of socially important diseases. Along with our own drug |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.19.9.1 Date: Fri, 24 Dec 2021 12:02:25 GMT Content-Type: text/html Content-Length: 17458 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Sat, 27 Feb 2016 05:35:23 GMT ETag: "4432-52cb9c8423de0" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
zylacta.com Whois Information
Domain Name: ZYLACTA.COM Registry Domain ID: 136858542_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-12-10T21:22:36Z Creation Date: 2004-12-07T21:30:50Z Registry Expiry Date: 2022-12-07T21:30:50Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS57.WORLDNIC.COM Name Server: NS58.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-28T08:13:40Z <<< |